[HTML][HTML] EANM Dosimetry Committee series on standard operational procedures for internal dosimetry for 131I mIBG treatment of neuroendocrine tumours
J Gear, C Chiesa, M Lassmann, PM Gabiña, J Tran-Gia… - EJNMMI physics, 2020 - Springer
The purpose of the EANM Dosimetry Committee Series on “Standard Operational
Procedures for Dosimetry”(SOP) is to provide advice to scientists and clinicians on how to …
Procedures for Dosimetry”(SOP) is to provide advice to scientists and clinicians on how to …
Dosimetry for 131I-MIBG therapies in metastatic neuroblastoma, phaeochromocytoma and paraganglioma
F Sudbrock, M Schmidt, T Simon, W Eschner… - European journal of …, 2010 - Springer
Purpose Radiation dosimetry is a basic requirement for targeted radionuclide therapies
(TRT) which have become of increasing interest in nuclear medicine. Despite the significant …
(TRT) which have become of increasing interest in nuclear medicine. Despite the significant …
Patient dosimetry for 131I-MIBG therapy for neuroendocrine tumours based on 123I-MIBG scans
M Monsieurs, B Brans, K Bacher, R Dierckx… - European journal of …, 2002 - Springer
Pre-therapeutic metaiodobenzylguanidine (MIBG) scans can be performed using labelling
with either iodine-123 or iodine-131. 123 I-MIBG scans provide better image quality and …
with either iodine-123 or iodine-131. 123 I-MIBG scans provide better image quality and …
Patient dosimetry after 131I-MIBG therapy for neuroblastoma and carcinoid tumours
MA Monsieurs, HM Thierens, A Vral… - Nuclear medicine …, 2001 - journals.lww.com
Aim The aim of the study was to determine the equivalent total body dose (ETBD) using the
cytokinesis-blocked micronucleus assay in 22 131 I-meta-iodobenzylguanidine (131 I-MIBG) …
cytokinesis-blocked micronucleus assay in 22 131 I-meta-iodobenzylguanidine (131 I-MIBG) …
Whole-body dosimetry for individualized treatment planning of 131I-MIBG radionuclide therapy for neuroblastoma
SE Buckley, SJ Chittenden, FH Saran… - Journal of Nuclear …, 2009 - Soc Nuclear Med
The aims of this study were to examine the relationship between whole-body absorbed dose
and hematologic toxicity and to assess the most accurate method of delivering a prescribed …
and hematologic toxicity and to assess the most accurate method of delivering a prescribed …
[HTML][HTML] EANM enabling guide: how to improve the accessibility of clinical dosimetry
J Gear, C Stokke, C Terwinghe, S Gnesin… - European Journal of …, 2023 - Springer
Dosimetry can be a useful tool for personalization of molecular radiotherapy (MRT)
procedures, enabling the continuous development of theranostic concepts. However, the …
procedures, enabling the continuous development of theranostic concepts. However, the …
Correlation of tumor and whole-body dosimetry with tumor response and toxicity in refractory neuroblastoma treated with 131I-MIBG
KK Matthay, C Panina, J Huberty, D Price… - Journal of Nuclear …, 2001 - Soc Nuclear Med
The purpose of our study was to determine the effect of tumor-targeted radiation in
neuroblastoma by correlating administered 131I-metaiodobenzylguanidine (MIBG) activity to …
neuroblastoma by correlating administered 131I-metaiodobenzylguanidine (MIBG) activity to …
EANM Dosimetry Committee guidance document: good practice of clinical dosimetry reporting
M Lassmann, C Chiesa, G Flux, M Bardiès - European journal of nuclear …, 2011 - Springer
Many recent publications in nuclear medicine contain data on dosimetric findings for existing
and new diagnostic and therapeutic agents. In many of these articles, however, a description …
and new diagnostic and therapeutic agents. In many of these articles, however, a description …
131I/123I-Metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging
E Bombardieri, F Giammarile, C Aktolun… - European journal of …, 2010 - Springer
The aim of this document is to provide general information about mIBG scintigraphy in
cancer patients. The guidelines describe the mIBG scintigraphy protocol currently used in …
cancer patients. The guidelines describe the mIBG scintigraphy protocol currently used in …
Dosimetry for Fractionated 131I-mIBG Therapies in Patients with Primary Resistant High-Risk Neuroblastoma: Preliminary Results
This paper describes the development of a protocol for SPECT-based tumor dosimetry for
131I-mIBG therapy patients with high-risk neuroblastoma. The treatment aims to deliver a …
131I-mIBG therapy patients with high-risk neuroblastoma. The treatment aims to deliver a …